Fibrogen Inc. buy BiotechBee
Start price
25.01.24
/
50%
€0.88
Target price
25.01.25
€1.30
Performance (%)
143.18%
End price
19.02.24
€2.14
Summary
This prediction ended on 19.02.24 with a price of €2.14. With a performance of 143.18% the BUY prediction by BiotechBee was a big success. BiotechBee has a follow-up prediction for Fibrogen Inc. where he still thinks Fibrogen Inc. is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Fibrogen Inc. | 2.560% | 2.560% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
According to BiotechBee what are the pros and cons of Fibrogen Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Fibrogen Inc. diskutieren
Buy mit Kursziel 1,3
In the thread Trading Fibrogen Inc.
Buy beendet
Current prediction by BiotechBee for Fibrogen Inc.
Fibrogen Inc.
Start price
Target price
Perf. (%)
€2.14
19.02.24
19.02.24
€6.00
31.07.27
31.07.27
-51.85%
10.05.24
10.05.24
Could be very worthwhile Investment >20% year